Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Leukemia · High Risk Acute Lymphoblastic Leukemia · High Risk Acute Myeloid Leukemia · Relapse Leukemia · MDS (Myelodysplastic Syndrome) · Relapsed Non-Hodgkin Lymphoma · Acquired Aplastic Anemia · Inherited BMF Syndrome · Immunodeficiency · Primary Immune Regulatory Disorder · Hemoglobinopathies · Bone Marrow Failure · Inborn Errors of Metabolism · HLH

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Megan Atkinson) · atkinsonm@chop.edu · 215-590-2820
Study leads
  • Timothy Olson, MD, PhD

    Principal Investigator

    Children's Hospital of Philadelphia